Pfizer-BioNTech's COVID Vaccine Gets Full Approval From The FDA

Posted over 1 year ago in IMPORTANT NEWS

Updated August 23, 20212:58 PM ET

by Scott Hensley NPR Prairie Public

The Food and Drug Administration has formally approved Pfizer's COVID-19 vaccine. The widely anticipated decision replaces the emergency use authorization granted by the agency last December.

The vaccine, developed by Pfizer and its partner BioNTech, is the first COVID-19 vaccine to be subject to a full review by the U.S. regulator and to get an approval that puts the vaccine on par with other marketed vaccines.

The full approval could make it easier for employers, the military and universities to mandate vaccination and may reassure some people who are hesitant about the vaccine.